Search results
Results from the WOW.Com Content Network
The former head of Australian liver-cancer treatment firm Sirtex Medical Ltd has pleaded guilty to insider trading, Australia's corporate regulator said on Wednesday. Gilman Edwin Wong, who headed ...
Australian liver cancer treatment maker Sirtex Medical Ltd expects its $1.4 billion buyout by a Chinese consortium to will win regulatory approval in Australia and the United States despite ...
Sirtex Medical Limited is a medical device firm that offers radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. [1] Sirtex was founded in 1997 in Australia and today has offices and production facilities in the U.S. , Australia , Germany , and Singapore .
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
The acquisition of Sirtex will fortify Varian Medical's (VAR) footprint in Australia. The transaction is likely to close in late May 2018. Varian Medical Receives Regulatory Nod for Sirtex Buyout
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Sirtex Medical: Interim report - half-year ended 31 December 2012 Net profit after tax (NPAT) increased 27.6 per cent to $7.8 million Global dose sales growth of 30.5 per cent Total revenue ...
For premium support please call: 800-290-4726 more ways to reach us